0
Laboratory and Animal Investigations |

Nonselective Endothelin-Receptor Antagonism Attenuates Hemodynamic Changes After Massive Pulmonary Air Embolism in Dogs*

Jose E. Tanus-Santos, MD, PhD; Wladimir M. Gordo, PharmD, MSc; Artur Udelsmann, MD; Máira H. Cittadino, BSc; Heitor Moreno, Jr., MD, PhD
Author and Funding Information

*From the Department of Pharmacology (Drs. Tanus-Santos, Gordo, Cittadino, and Moreno), and the Department of Anesthesiology and Research Laboratory of Anesthesia (Dr. Udelsmann), State University of Campinas, Campinas, São Paulo, Brazil.

Correspondence to: Heitor Moreno, Jr., MD, PhD, Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, PO Box 6111, 13083–970 Campinas, São Paulo, Brazil; e-mail: hmoreno@uol.com.br



Chest. 2000;118(1):175-179. doi:10.1378/chest.118.1.175
Text Size: A A A
Published online

Study objectives: To evaluate the effects of nonselective endothelin (ET)-receptor antagonism on the hemodynamic changes and serum thromboxane (TX)-A2 levels after a massive pulmonary air embolism (PAE) in dogs.

Design: Prospective trial.

Setting: University laboratory.

Interventions: Anesthetized mongrel dogs (ET-receptor antagonist group; n = 6) received a bolus injection of 1 mg of the nonselective ET-A/ET-B-receptor antagonist PD 145065 (Sigma Chemical; St. Louis, MO), and dogs in the control group (n = 6) received saline solution. Hemodynamic data were recorded 5 min after the administration of antagonist or saline solution. Subsequently, each dog received 2.5-mL air/kg via the right femoral vein (the PAE), and the hemodynamic data were recorded for up to 60 min thereafter. Arterial blood samples were drawn at baseline and 15 min after PAE for the determination of plasma TX-A2, measured by enzyme-linked immunosorbent assay as TX-B2 (the stable metabolite of TX-A2).

Results: PD 145065 alone produced no hemodynamic effects. However, dogs pretreated with PD 145065 had significantly lower increases in mean pulmonary arterial pressure and in pulmonary vascular resistance after the PAE (116% and 165%, respectively) compared to the control dogs (187% and 367%, respectively). The mean arterial pressure (MAP), cardiac index (CI), and plasma TX-B2 levels were unaltered after PAE in the presence of ET-receptor antagonist, whereas CI and MAP decreased 5 to 10 min after PAE, and TX-B2 concentrations increased 15 min after PAE in control dogs (p < 0.05 in all cases).

Conclusions: Nonselective antagonism of ET receptors attenuates the pulmonary hypertension and blunts the TX-A2 release caused by massive PAE in dogs.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543